Literature DB >> 21690432

Measures to improve safety of an elastomeric infusion system for pain management.

Kara L Birrer1, Rebecca L Anderson, Xi Liu-DeRyke, Kuldip R Patel.   

Abstract

PURPOSE: Measures to improve the safe implementation and utilization of an elastomeric infusion system for pain management are described.
SUMMARY: Due to the multiple safety concerns associated with the use of the On-Q infusion systems (I-Flow Corporation, Lake Forest, CA) in a community-based teaching institution, a multidisciplinary team of physicians, pharmacists, clinical nurses, nurse educators, and computer informatics personnel was formed to develop a standardized policy and procedure to ensure the safe use of On-Q pumps. The policy addressed several problems concerning prescribing, dispensing, administration, and monitoring of these pumps. The patient care policy for use of On-Q pumps dictates how the pumps are stocked, ordered, dispensed, administered, and monitored and the drugs approved for use in the pumps. Education bulletins, a summary of the new policy and procedure, and a formal presentation of the policy and procedure to unit-based nurse educators were provided. The focus was on a consistent message of safety by reiterating the problems described with these pumps in the literature and in the health care system itself. The physicians ordering the devices have provided positive feedback regarding the simplified ordering process and standardization of the pumps, medications, and concentrations. Both dispensing pharmacists and bedside nurses have noted that the orders are clearly communicated via the computerized system. The addition of documentation in the computer system and education regarding potential signs and symptoms of adverse events with the medication used with the pumps was greatly appreciated by the nursing staff.
CONCLUSION: A health care system instituted measures to enhance the safety of using an elastomeric infusion system for pain management.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21690432     DOI: 10.2146/ajhp100558

Source DB:  PubMed          Journal:  Am J Health Syst Pharm        ISSN: 1079-2082            Impact factor:   2.637


  3 in total

1.  Impact of liposome bupivacaine on the adequacy of pain management and patient experiences following aesthetic surgery: Results from an observational study.

Authors:  Michael C Edwards; Evan Sorokin; Mark Brzezienski; Farzad R Nahai; Richard Scranton; Holly Wall; Simeon Wall; Stephan Finical; Kevin Smith
Journal:  Plast Surg (Oakv)       Date:  2015       Impact factor: 0.947

2.  Implementation and Postoperative Management of Continuous Adductor Canal Catheters for Total Knee Arthroplasty to Reduce Surgical Backlog Related to the COVID-19 Pandemic: An Acute Pain Service Nursing Perspective and Educational Resource.

Authors:  Tara J Faraoni; Richelle Kruisselbrink
Journal:  J Perianesth Nurs       Date:  2022-04-29       Impact factor: 1.295

3.  A randomized, multicenter, pilot study comparing the efficacy and safety of a bupivacaine-collagen implant (XaraColl(®)) with the ON-Q PainBuster(®) Post-op Pain Relief System following open gynecological surgery.

Authors:  Susan L Cusack; Harold S Minkowitz; Michael Kuss; Mark Jaros; Lisa Hemsen
Journal:  J Pain Res       Date:  2012-11-02       Impact factor: 3.133

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.